Adjuvant Therapy for Early-Stage HER2-Positive Breast Cancer

Empowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 InhibitionПодробнее

Managing Central Nervous System Metastasis in Patients With HER2-Positive Breast CancerПодробнее

Dr Thompson on the Necessity of Surgery and Radiation Therapy in Early-Stage Breast CancerПодробнее

Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and ToxicityПодробнее

Dr Thompson on Trials Evaluating De-Escalated Treatment in Early-Stage Breast CancerПодробнее

NATALEE - Addition of Ribociclib to Endocrine Therapy in Adjuvant Settings - Breast Cancer ESMO 2024Подробнее

Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OSПодробнее

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancerПодробнее

Dr Yee on Neoadjuvant Datopotamab Deruxtecan in High-Risk, Early-Stage Breast CancerПодробнее

Trial Demonstrates High Efficacy of Antibody Drug Conjugate in Preventing Early Stage Breast CancerПодробнее

Role of chemotherapy in early hormone receptor-positive breast cancerПодробнее

HERA Indicates that Adjuvant Trastuzumab Confers Equal Benefit for HER2-Positive Invasive Ductal ...Подробнее

Adjuvant PARP Inhibitors in Patients with High-risk Early-Stage HER2-Negative Breast Cancer and G...Подробнее

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline...Подробнее

02_08 Early HER-2 positive breast cancerПодробнее

Breast Cancer Adjuvant Systemic Therapy Prof. Sarin's Teaching RoundsПодробнее

Ribociclib in Early Breast Cancer | NEJMПодробнее

JCO Article Insights: Elderly Patients Receiving Chemotherapy for Early-Stage Breast CancerПодробнее

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline UpdateПодробнее

Pertuzumab (Perjeta) Injection: Uses, Dosage, Mechanism, Side Effects, and Important AdviceПодробнее